The largest database of trusted experimental protocols

11 protocols using dpni

1

Site-Directed Mutagenesis of Helicobacter pylori CagL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Site-directed mutagenesis of CagL was performed using the pAD1 vector as DNA template [9] (link). As shown in Figure 1B, CagL of GC strains contain the amino acids Tyr-Glu-Ile-Gly-Lys (YEIGK) at position 58–62 of the protein, while strain 26695 has the amino acids Asn-Glu-Met-Gly-Glu (NEMGE) at this position. To generate a CagL 26695YE mutant (Figure 1B, bottom), we performed PCR reactions with the following primers: 628F 5′-GGTAAAGAAGATGCTCTAAACATC and 628R 5′-GATTTCATAATTAGCACTAGGGCTAG to open and amplify the entire construct. For amplification, Phusion® High-Fidelity DNA Polymerase (NEB, Ipswich, USA) was used, followed by PCR purification (MinElute PCR Purification Kit, Qiagen, Hilden, Germany), digestion with DpnI (Promega, Madison, USA), and ligation using T4 DNA Ligase (Promega). Re-sequencing and Western blotting of E. coli or H. pylori lysates, respectively, verified the appropriate expression of CagL mutant variants from the resulting plasmids.
+ Open protocol
+ Expand
2

Generating Adenovirus Mutants via Recombineering

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the first step, the galactokinase (GalK) cassette was amplified by PCR from the pGalK plasmid using primers that carried 45–base pair homology sequences directly up- or downstream of the protein V coding region (see table S2, primers GalK_f and GalK_r). The PCR product was purified by gel extraction and digested with Dpn I (Promega) for 1 hour to remove residual template DNA before a second round of purification. Electrocompetent Escherichiacoli SW102 cells harboring the AdV-C5 containing bacmid (pKSB2) were then electroporated with the purified PCR construct. Positive clones were verified by sequencing and underwent a second electroporation reaction. In the case of AdV-C5-ΔV, this was done with a dsDNA oligonucleotide (dV_f and dV_r; table S2) consisting of the left and right homology sequences. For the AdV-C5-V-KR mutant, the recombination substrate was a synthesized modified protein V DNA sequence in which all lysine codons were replaced by arginine codons flanked by the left and right homology arms (table S2; synthesized by Thermo Fisher Scientific). The resulting AdV-C5-V-KR bacmid then served as the template for constructing the AdV-C5-V-KRrev* mutant. Bacmid DNA from positive clones was extracted, digested with Pac I to release the AdV genome, and transfected into HER911 cells. Rescued viruses were plaque-purified, expanded, and verified by sequencing.
+ Open protocol
+ Expand
3

Mutating Human TRPM8 and TRPA1 Channels

Check if the same lab product or an alternative is used in the 5 most similar protocols
A series of mutations were made at sites affecting the structure of human TRPM8 or TRPA1 (Figures 1a and 3a). Oligonucleotides were purchased from Eurofins-MWG-Operon. Mutated TRP channel cDNAs were created in plasmid pcDNA3.1neo(+) using quick-change PCR mutagenesis with velocity DNA polymerase (Bioline)-mediated amplification. Methylated template DNA was removed by digestion with DpnI (Promega) and mutated plasmids were cloned and isolated following transformation of competent Escherichia coli (Bioline). DNA sequences were confirmed using automated sequencing (Eurofins Genomics) with appropriate primers.
+ Open protocol
+ Expand
4

Cloning and Mutagenesis of SLC5A5 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human genomic sequence containing exons 11 (87 nucleotides) and 12 (197 nucleotides) of the SLC5A5 gene along with the last 311 nucleotides of intron 10, the 82 nucleotides of intron 11, and the first 367 nucleotides of intron 12 were amplified by PCR using the following primers containing XhoI and BamHI restriction sites (underlined) 5’- CACACTCGAGGTTGCAGTGAGCCAAGATCG (forward) and 5’- TGTGGGATCCTCAAGCTGGGAGGATTGC (reverse). PCR primers were designed using the Primer3 server (http://frodo.wi.mit.edu/). The DNA fragments were cloned into the corresponding cloning sites of the splicing reporter pSPL3 vector (a discontinued product of Thermo-Fisher Scientific) (20 (link)). Site-directed mutagenesis was performed by PCR with oligonucleotides carrying the desired mutation using Phusion Hot Start II DNA Polymerase (Thermo-Fisher Scientific), which was followed by template plasmid digestion with DpnI (Promega – Madison, WI) (21 (link)). Oligonucleotides for site-directed mutagenesis were designed using QuikChange Primer Design Program (Agilent Technologies, Santa Clara, CA). All constructs were sequenced to verify specific nucleotide substitutions (Macrogen).
+ Open protocol
+ Expand
5

Site-directed mutagenesis of FBD variant

Check if the same lab product or an alternative is used in the 5 most similar protocols
The T168V variant of rFBD was obtained by applying the QuikChange site-directed mutagenesis protocol established by Stratagene with the plasmid pFBD and the primers FBD-T168V-F/R. The resulting PCR product was digested for 1 h at 37°C with 1 μL of DpnI (Promega), prior to transformation into E. coli DH5α as described above. The mutation was verified by sequencing.
+ Open protocol
+ Expand
6

Site-directed Mutagenesis of RXFP1 Receptor

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length human RXFP1 in pcDNA3.1/Zeo(+) AmpR mammalian expression vector (Invitrogen, Carlsbad, CA) containing an N-terminal FLAG tag and a bovine prolactin signal sequence was used as a template for site-directed mutagenesis.23 (link) The FLAG tag does not interfere with receptor activity.24 (link) Mutant DNA was prepared using long-range PCR with PfuTurbo® DNA polymerase (Agilent Technologies, Santa Clara, CA, USA) with overlapping primers containing the mutated nucleotide sites. The template was digested with DpnI (Promega, Madison, WI) and the DNA was transformed into XL10-Gold ultracompetent cells (Agilent Technologies). The cDNA of mutant clones was fully sequenced to confirm the presence of the correct mutations and the absence of additional substitutions.
+ Open protocol
+ Expand
7

Site-Directed Mutagenesis of ID Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
In-vitro site-directed mutagenesis was performed by using cloned Pfu DNA polymerase (Agilent technologies) on bacterial expression plasmids. The PCR product was first digested overnight with Dpn-I (Promega) and then used to transform JM101 super-competent cells (Agilent). All the mutants were verified by DNA sequencing (Applied Biosciences). Mutations in the HLH domains of ID1 (S74P) and ID4 (S73P) were introduced by PCR using complementary primers incorporating specific site mutations (see below). The deletion of the alanine stretch towards N-terminal of the HLH domain was performed by generating BamH1 sites flanking the alanine stretch (residues 39–48). The resultant plasmid was digested with BamH1, re ligated and transformed.
ID4 site directed mutation from Serine to proline (S73P)
ID1 site directed mutation from Serine to proline (S74P)
ID4 alanine deletion BamH1 site-1
ID4 alanine deletion BamH1 site-2
+ Open protocol
+ Expand
8

MMP2 5'UTR Smad3 Binding Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A point mutation of the predicted Smad binding site (5′-AGACTTCCC-3′) on 5′ UTR of MMP2 was introduced with DpnI (Promega, WI, USA) after linear amplification and then sequenced to confirm the desired mutation (5′-TCTGAAGGG-3′). The primers used for amplification are forward: 5′- GCCCGCCCTTGTTTCCGCTGCATCCTCTGAAGGGTGGTGGCTGGAGGCTCTGTGTGCAT-3′ and reverse: 5′-ATGCACACAGAGCCTCCAGCCACCACCCTTCAGAGGATGCAGCGGAAACAAGGGCGGGC-3′. The original or point-mutated 5′ UTR sequences of MMP2 were cloned into psi-CHECK2 Luciferase Reporter Vectors. The coding sequence of mouse Smad3 was also cloned into pcDNA3.1+.
293T cells were transfected with the pGL3-MMP2 or pGL3-mutMMP2 plasmid using Lipofectamine 2000 (Invitrogen), and pcDNA3.1+-Smad3 plasmid was co-transfected into the cells to enhance the expression of mouse Smad3. The luciferase activities were analyzed by Dual-Luciferase Reporter Assay System (Promega, WI, USA).
+ Open protocol
+ Expand
9

Site-directed mutagenesis of HBV plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGEM-HBV1.3 (Mut) was mutated at the binding site of ZEB2 with PCR. In brief, the HBV sequence was amplified from pGEM-HBV1.3 by PCR using the sense primer P1 (5′-cggaccgtgtgcacttcgcttcgtatctgcacgtagcatggagaccaccg-3′) and the antisense primer P2 (5′-cggtggtctccatgctacgtgcagatacgaagcgaagtgcacacggtccg-3′). The sense primer and the antisense primer were reverse compliment, and the primer contained the mutated ZEB2 binding sites. Then, the PCR product was purified and digested with DpnI (Promega; USA). After digestion, the mutated pGEM-HBV1.3 was obtained by electro-transformation and extracted by Plasmid Mini Kit (OMEGA; USA). Finally, the mutated pGEM-HBV1.3 was identified by DNA sequencing.
+ Open protocol
+ Expand
10

Plasmid Mutagenesis and Sequencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes were cloned in the plasmid vectors listed in Supplementary Table S3.
Mutations were introduced on genes via the QuickChange Site-Directed Mutagenesis protocol (Stratagene-Agilent) using the indicated templates and primers (see supplementary Table S3). Restriction enzymes and T4 DNA Ligase were purchased from Promega. For PCR mutagenesis PFU Ultra Polymerase (Stratagene) was used;
for gene amplification either Expand High fidelity Polymerase (Roche) or PFU Ultra polymerase (Promega). DpnI was used to cleave the maternal methylated DNA (Promega). Primers (Supplementary Table S4) were synthesized by Eurogentec (Belgium). All PCR-generated plasmids were sequenced (Macrogen Europe).
Plasmids were stored in DH5α cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!